Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

59.9K
Overview
59.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

892
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
892
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

815
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
815
Optimal Foraging00:48

Optimal Foraging

13.8K
How animals obtain and eat their food is called foraging behavior. Foraging can include searching for plants and hunting for prey and depends on the species and environment.
13.8K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potentially modifiable ventilatory factors contributing to outcome in patients with pulmonary and extrapulmonary ARDS - An individual patient data analysis.

Journal of clinical anesthesia·2026
Same author

Effect of prone positioning on pathophysiology and lung histopathology during VV-ECMO in severe ARDS: an experimental animal study.

Critical care (London, England)·2026
Same author

Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes.

Pneumonia (Nathan Qld.)·2025
Same author

MicroRNA mapping of bronchial aspirate for molecular phenotyping and prognostication in patients on mechanical ventilation.

Molecular therapy. Nucleic acids·2025
Same author

Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities.

Scientific reports·2025
Same author

Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter study.

Anaesthesia, critical care & pain medicine·2025
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.0K

Optimizing Antibiotic Administration for Pneumonia.

Ana Motos1, James M Kidd2, David P Nicolau3

  • 1Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA; Division of Animal Experimentation, Department of Pulmonary and Critical Care, Hospital Clinic, 170 Villarroel Street, Barcelona 08036, Spain.

Clinics in Chest Medicine
|November 5, 2018
PubMed
Summary
This summary is machine-generated.

Optimizing antibiotic efficacy is crucial for treating bacterial pneumonia, including hospital-acquired and ventilator-acquired types. This review explores pharmacokinetic and pharmacodynamic strategies to improve antibacterial treatment in critical illness.

Keywords:
Community-acquired bacterial pneumoniaCritical illnessHospital-acquired bacterial pneumoniaPharmacodynamicsPharmacokineticsVentilator-acquired bacterial pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.7K

Related Experiment Videos

Last Updated: Feb 3, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.7K

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Bacterial pneumonia, encompassing community-acquired, hospital-acquired, and ventilator-acquired types, presents significant morbidity and mortality.
  • Antimicrobial resistance and treatment failures necessitate improved antibiotic strategies.
  • Optimization of antibiotic efficacy is a critical priority in managing pneumonia.

Purpose of the Study:

  • To review pharmacokinetic and pharmacodynamic (PK/PD) approaches for optimizing antibacterial therapy in pneumonia.
  • To focus on PK/PD strategies within the lung environment and in critically ill patients.
  • To discuss the integration of these PK/PD approaches into drug development and clinical practice.

Main Methods:

  • Literature review focusing on pharmacokinetic and pharmacodynamic principles.
  • Analysis of strategies for antibacterial optimization in the lung.
  • Examination of PK/PD applications in critical illness and drug development.

Main Results:

  • PK/PD approaches offer a rational basis for optimizing antibiotic dosing and selection.
  • Tailoring antibiotic therapy based on PK/PD targets can enhance efficacy against resistant pathogens.
  • Integration of PK/PD principles is vital for successful drug development and improved clinical outcomes.

Conclusions:

  • Pharmacokinetic and pharmacodynamic optimization is essential for improving treatment outcomes in bacterial pneumonia.
  • These strategies are particularly important in the context of multidrug resistance and critical illness.
  • Implementing PK/PD-guided therapy can enhance antibiotic efficacy and reduce treatment failures.